Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From India-Reference-Cited by-同舟云学术

Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From India

Published:2018-06 Issue:2 Volume:8 Page:121-124
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Choudhary Narendra S.,Saigal Sanjiv,Gautam Dheeraj,Saraf Neeraj,Rastogi Amit,Goja Sanjay,Bhangui Prashant,Soin Arvinder S.

Publisher

Elsevier BV

Subject

Hepatology

Reference23 articles.

1. Natural history of recurrent hepatitis C;Berenguer;Liver Transpl,2002

2. Recurrent hepatitis C after liver transplantation;Dumortier;World J Gastroenterol,2014

3. Long-term outcome of hepatitis C infection after liver transplantation;Gane;N Engl J Med,1996

5. Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation;Berenguer;Am J Transpl,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03

2. Liver transplantation: the recipient;Living Donor Organ Transplantation;2024

3. Long-term Management of the Adult Liver Transplantation Recipients;Journal of Clinical and Experimental Hepatology;2021-03

4. Outcome of hepatitis C–related liver transplantation in direct-acting antiviral era;Indian Journal of Gastroenterology;2020-11-24

5. Essential updates 2018/2019: Liver transplantation;Annals of Gastroenterological Surgery;2020-02-25